About Vaxxel
Vaxxel is an Innovative viral live-attenuated platform for intranasal vaccine candidates preventing against pneumovirus infections
Founded in 2019 by Denis Cavert.
- Founded
- 2019
- Employees
- 11 to 50
- Total funding
- $1.2M
Jobs at Vaxxel
No open positions right now. Explore more companies on TheJobsMap.